Adaptive Biotechnologies Corporation (ADPT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.46B |
| Enterprise Value | 2.67B |
| P/E Ratio | -64.32 |
| PEG Ratio | -0.5 |
| Price/Sales Ratio | 11.41 |
| Price/Book Ratio | 15.14 |
| Enterprise/Revenue | 11.85 |
| Enterprise/EBITDA | -158.93 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.17 |
| Operating Margin | -0.16 |
| Return On Assets | -0.1 |
| Return On Equity | -0.24 |
| Revenue | 276.98M |
| Revenue/Share | 1.9 |
| Gross Profit | 205.62M |
| EBITDA | -29.85M |
| Net Income | -59.5M |
| Diluted EPS | -0.39 |
| Total Cash | 218.33M |
| Total Cash/Share | 1.4 |
| Total Debt | 208.18M |
| Total Debt/Equity | 0.96 |
| Current Ratio | 3.35 |
| Book Value Per Share | 1.44 |
| 52-Week Change | 82.34 |
| 52-Week High | 22.8 |
| 52-Week Low | 9.96 |
| Moving Average 50 Days | 16.6 |
| Moving Average 200 Days | 15.98 |
| Average Volume | 2.53M |
| Shares Outstanding | 160.04M |
| % Held by Institutions | 99.17 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | July 15, 2026 |